Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug [Yahoo! Finance]
Solid Biosciences Inc. (SLDB)
Last solid biosciences inc. earnings: 8/14 07:25 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.solidbio.com/investor-relations
Company Research
Source: Yahoo! Finance
candidate, SGT-003, which is being developed as a gene therapy for Duchenne muscular dystrophy (DMD). The Rare Pediatric Disease designation is granted by the FDA to medicines that treat serious or life-threatening diseases, usually affecting less than 200,000 children in the United States aged 18 years and less. Upon potential approval for SGT-003 by the FDA, the company may become eligible to receive a priority review voucher. This priority review voucher can be used either by SLDB in a subsequent marketing application filed with the FDA for a different product or may even be sold to any other third party to boost cash reserves. Despite the positive regulatory update for the DMD candidate, shares of the company were down 6.6% on Apr 1. However, the stock recovered soon after and was up 2% in after-hours trading on Monday. Year to date, shares of Solid Biosciences have skyrocketed 102.6% compared with the industry's increase of 0.4%. Image Source: Zacks Investment Research
Show less
Read more
Impact Snapshot
Event Time:
SLDB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLDB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLDB alerts
High impacting Solid Biosciences Inc. news events
Weekly update
A roundup of the hottest topics
SLDB
News
- Buy Solid Biosciences: Unpacking Its Main Value Driver [Seeking Alpha]Seeking Alpha
- British billionaire fined $5M, sentenced to 3 years probation for insider trading [Yahoo! Finance]Yahoo! Finance
- Joe Lewis: How one of Britain's richest people broke insider trading laws [Yahoo! Finance]Yahoo! Finance
- Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]Yahoo! Finance
- Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
SLDB
Earnings
- 11/8/23 - Beat
SLDB
Sec Filings
- 4/26/24 - Form ARS
- 4/26/24 - Form DEFA14A
- 4/26/24 - Form DEF
- SLDB's page on the SEC website